lilly tirzepatide trial New clinical trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Eli Lilly Finds Yet Another

Semaglutide 2

GLP-1 Weight Loss Treatments in Peoria, Arizona GLP-1 medications like semaglutide and tirzepatide have changed how medical providers approach weight loss

SGLT2 inhibitors during pregnancy Animal None of the SGLT2 inhibitors showed developmental toxicity when a dose not resulting in maternal toxicity was administered during the interval coinciding with the first trimester period of organogenesis except for canagliflozin, where ossification delays of the metatarsal bones were seen ( Table 2 )

I havent seen any law firm client alerts on this yet, but if you operate in the GLP-1 space, this is worth paying attention to

We also have natural appetite suppressants if you want a natural alternative to conventional medications that suppress appetites like phentermine and semaglutide